Latest Taxation News

Page 3 of 27
Australia and New Zealand Banking Group Limited (ANZ) has announced a quarterly distribution of AUD 1.4438 per security on its capital notes, payable in June 2026, with a 70% franking component and tax considerations for investors.
Victor Sage
Victor Sage
26 Mar 2026
Alcoa Corporation has updated its dividend notification for the quarter ending December 2025, clarifying currency exchange rates and payment methods for its shareholders.
Maxwell Dee
Maxwell Dee
24 Mar 2026
Atlas Arteria has announced an ordinary dividend of AUD 0.20 per security for the six months ending December 2025, payable in April 2026. The dividend is fully unfranked, reflecting foreign income components.
Nora Hopper
Nora Hopper
20 Mar 2026
Adelong Gold Limited has received a $1.17 million tax indemnity claim linked to alleged fraudulent GST reporting at Challenger Mines, which it plans to dispute. The claim stems from activities predating the current management team.
Maxwell Dee
Maxwell Dee
18 Mar 2026
Resonance Health has received a $732,851 refund from the Australian Taxation Office, reflecting its FY2025 R&D tax incentive claim net of income tax payable. This cash inflow strengthens the company’s financial position ahead of its March quarterly report.
Ada Torres
Ada Torres
16 Mar 2026
FAR Limited has agreed on a provisional US$23.7 million contingent payment from Woodside Energy tied to the Sangomar Project, prompting a proposed capital return of A$32.3 million to shareholders.
Maxwell Dee
Maxwell Dee
16 Mar 2026
The Brazilian government has imposed a 12% tax on crude oil exports effective immediately, a move framed as windfall profit sharing amid high oil prices. Karoon Energy, with significant Brazilian operations, faces new cost pressures as the tax awaits potential ratification by Congress.
Maxwell Dee
Maxwell Dee
13 Mar 2026
Janus Electric has locked in a $2.75 million R&D finance facility, strengthening its cash position to push forward with its zero-emission transport innovations. This strategic funding avoids shareholder dilution while supporting ongoing technology development.
Victor Sage
Victor Sage
9 Mar 2026
Chimeric Therapeutics has secured a $1.785 million advance against its anticipated FY26 Research and Development Tax Incentive to bolster its clinical trial pipeline and working capital.
Ada Torres
Ada Torres
2 Mar 2026
Betashares Capital Ltd has announced the final distribution amounts for February 2026 across a broad range of its ETFs listed on the ASX AQUA market, alongside details on the Distribution Reinvestment Plan.
Claire Turing
Claire Turing
27 Feb 2026
Hydrix Limited reported a 14% revenue decline and a sharp increase in net loss for H1 2026, raising concerns about its financial stability despite securing a major contract.
Ada Torres
Ada Torres
27 Feb 2026
Careteq Limited reported a widening half-year loss with revenues down 18%, announcing plans to sell its Embedded Health Solutions business to strengthen its balance sheet and focus on its HMR Referral platform.
Ada Torres
Ada Torres
26 Feb 2026